1. Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection 
Steven L. Flamm, Eric Lawitz, Ira Jacobson, Marc Bourlière, Christophe Hezode, John M. Vierling, Bruce R. Bacon, Claus Niederau, Morris Sherman, Venkata Goteti, Heather L. Sings, Richard O. Barnard, John A. Howe, Lisa D. Pedicone, Margaret H. Burroughs, Clifford A. Brass, Janice K. Albrecht, Fred Poordad 
Clinical Gastroenterology and Hepatology 
Volume 11, Issue 1, Pages e4 (January 2013)
DOI: /j.cgh
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Study design.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2 Patients with SVR, according to treatment group and analysis.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

4. Supplementary Figure 1
Randomization, end-of-treatment response, and SVR among the study population.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions